Immunisation campaign using oral cholera vaccine Shanchol cost effective in Malawi.
Předmět: | |
---|---|
Zdroj: | PharmacoEconomics & Outcomes News; 3/20/2021, Vol. 874 Issue 1, p18-18, 1p |
Abstrakt: | The reactive immunisation campaign using the oral cholera vaccine Shanchol, as implemented in response to a cholera outbreak in Malawi, can be considered cost effective. Cholera-related treatment costs averted by the immunisation campaign were estimated at $US79 789, and the net immunisation programme costs were estimated at $US317 569. [Extracted from the article] |
Databáze: | Complementary Index |
Externí odkaz: |